Merck KGaA (ETR:MRK) Shares Up 0.8%

Merck KGaA (ETR:MRK)’s stock price shot up 0.8% during mid-day trading on Tuesday . The company traded as high as €93.60 ($108.84) and last traded at €92.92 ($108.05), 494,693 shares were traded during trading. The stock had previously closed at €92.18 ($107.19).

The company has a debt-to-equity ratio of 53.69, a current ratio of 0.94 and a quick ratio of 0.58. The company has a market cap of $12.01 billion and a P/E ratio of 12.56. The company’s 50 day simple moving average is €93.43.

Merck KGaA Company Profile (ETR:MRK)

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments.

Further Reading: Consumer behavior in bull markets

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.